New shortage hits Pfizer drug

 Posted 28 November 2024 PM

A new anticipated shortage has hit Pfizer's PBS-listed high-strength Bicillin L-A antibiotic, with the TGA approving an overseas registered product available from this week to cover any potential supply gaps.

The company notified the regulator that an ongoing shortage of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) 600,000 unit prefilled syringes for injection is estimated to continue until April 2025. It also flagged a new anticipated shortage of the high-strength Bicillin L-A 1.2 million unit prefilled syringes for injection from 20 December 2024 to 10 January 2025.